CED Clinic
Medicinal cannabis is changing the face of clinical medicine. We are the leaders of that change.
CED Clinic
Medicinal cannabis is changing the face of clinical medicine. We are the leaders of that change.
A July 2, 2026 clinical trial found lower restless legs syndrome scores and less wake-after-sleep-onset with a low-dose THC/CBD product. The signal is interesting, but the 18-patient open-label design and MS-heavy cohort leave major caveats. Here is what…
Before you go
A one-page guide from Dr. Caplan, corrected with the latest published measurements. It is sent to your inbox when you join the newsletter.
Join the growing cannabis community and get new research explained in plain language, so you never miss the studies that matter.
Free. Unsubscribe anytime with one click.
Your privacy choices. We use essential cookies to run this site. With your permission we also use analytics cookies to see which pages help readers.
